Full Schedule

Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Peter Campbell – The Wellcome Trust Sanger Inst

Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Speaker: Karin Vanderkerken, PhD (she/her/hers) – Vrije Universiteit Brusssels

Speaker: Madhav V. Dhodapkar, MD, MBBS (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA

Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland

Speaker: Anthony Cirrincione, PhD – Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami

Speaker: Wen Zhou, PhD – Cancer Research Institute, Xiangya School of Medicine, Central South University

Speaker: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre

Speaker: Leif Bergsagel, MD – Mayo Clinic Arizona

Panelist: Rafael Fonseca, MD – Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA

Panelist: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University

Panelist: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre

Panelist: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona

Co-Chair: Monica Morris, MSc, RN – Myeloma UK

Co-Chair: Ioanna Tsatsou

Co-Chair: Monica Morris, MSc, RN – Myeloma UK

Co-Chair: Ioanna Tsatsou

Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Speaker: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK

Speaker: Jessica Chen, MS, FNP – MD Anderson Cancer Center

Speaker: Donna D. Catamero, ANP-BC – Mount Sinai Hospital

Speaker: Chloe Ray, AGPCNP-BC, OCN – Mount Sinai Hospital

Co-Chair: Beth Faiman, PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO – Cleveland Clinic Taussig Cancer Institute, Department of Hematology and Medical Oncology

Co-Chair: Matthias Hellberg-Naegele, MSc – Comprehensive Cancer Center Zurich

Speaker: Orla McCourt, PhD MCSP – University College London NHS Foundation Trust

Speaker: Joanne S. Land, BSc (she/her/hers) – NHS University College London Hospital, London, United Kingdom

Speaker: Emma Dowling, RN BSC – HCA Healthcare UK

Speaker: Houry Leblebjian

Speaker: Charise Gleason, NP-C – Winship Cancer Institute of Emory University

Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Speaker: Yi Lin, MD, PHD – Mayo Clinic, Rochester, MN, USA

Speaker: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC

Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Chair: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Co-Chair: Tiffany Richards

Co-Chair: Andrea D. Preston, MRPharmS (Consultant) (she/her/hers) – NHS / Sanius Health

Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney

Speaker: Monica Morris, MSc, RN – Myeloma UK

Speaker: Urvi A. Shah, MD (she/her/hers) – Myeloma Service, Memorial Sloan Kettering Cancer Center

Speaker: Rebecca Lu, MSN, FNP-C – MD Anderson

Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney

Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca

Co-Chair: S. Vincent Rajkumar, MD – Mayo Clinic

Speaker: Saad Z. Usmani, MD MBA FACP – Memorial Sloan Kettering Cancer Center

Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France

Speaker: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK

Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Speaker: Thomas Lund, MD, PhD (he/him/his) – Department of Hematology Odense University Hospital

Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Speaker: Panagiotis Malandrakis, MD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Speaker: S. Vincent Rajkumar, MD – Mayo Clinic

Panelist: Sergio Giralt, MD – Memorial Sloan Kettering Cancer Center

Panelist: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France

Panelist: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE

Panelist: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil

Panelist: Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy

Panelist: Bindu Kanapuru

Co-Chair: Morie A. Gertz, MD, MACP (he/him/his) – Mayo Clinic

Co-Chair: Hartmut Goldschmidt, MD – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)

Speaker: Camila Guerrero – Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369

Speaker: Annika Werly – Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Speaker: Charan T R Vegivinti, MD (he/him/his) – Jacobi Medical Center / Albert Einstein College of Medicine

Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Speaker: Albert Oriol, PhD (he/him/his) – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain

Co-Chair: Annemiek Broijl, MD, PhD (she/her/hers) – ErasmusMC

Co-Chair: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.

Speaker: Elizabeth D. Lightbody, PhD – Dana-Farber Cancer Institute

Speaker: Afsaneh Panahi, MSc – BC Cancer Research Centre/ University of British Columbia

Speaker: wei tan, Ph.D – The University of Texas MD Anderson Cancer Center

Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine

Speaker: Hao Mu, Principle Investigation (she/her/hers) – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Speaker: S. Vincent Rajkumar, MD – Mayo Clinic

Speaker: Siddhartha Mukherjee

Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA